Table 1.
Interventions to treat HCC patients with microvascular invasion | |
---|---|
Population | HCC patients diagnosed with MVI by pathology after curative resection and Child class A or B without macrovascular invasion and metastatic disease |
Intervention vs Comparison | TACE versus conservation therapy; pa-TACE versus re-resection/ radiofrequency ablation ablation; pa-TACE versus radiotherapy; sorafenib versus conservation therapy |
Outcomes | OS and/or RFS |
Study design | Retrospective study (PSM or not) and randomized clinical trial |
Pa-TACE postoperative adjuvant transarterial chemoembolization